Microbiological, Clinical, and Pharmacokinetic/Pharmacodynamic Data to Support EUCAST Aztreonam–Avibactam Minimum Inhibitory Concentration Susceptibility Breakpoints Against Enterobacterales

Authors

Institutions

Publication Details

Journal
Infectious Diseases and Therapy
Published
2025-11-21
DOI
https://doi.org/10.1007/s40121-025-01267-3
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microbiological, Clinical, and Pharmacokinetic/Pharmacodynamic Data to Support EUCAST Aztreonam–Avibactam Minimum Inhibitory Concentration Susceptibility Breakpoints Against Enterobacterales

Joseph W. Chow, Heidi Leister‐Tebbe, Gregory G. Stone, Elena Soto et al.
Infectious Diseases and Therapy
Antibiotic Resistance in Bacteria
article

Microbiological, Clinical, and Pharmacokinetic/Pharmacodynamic Data to Support EUCAST Aztreonam–Avibactam Minimum Inhibitory Concentration Susceptibility Breakpoints Against Enterobacterales

Joseph W. Chow, Heidi Leister‐Tebbe, Gregory G. Stone, Elena Soto, Francis F. Arhin, Susan Raber, Rujia Xie, Halley Rogers
article en

Abstract

No abstract available for this paper.
Infectious Diseases and TherapyVol. 15(1)
Pfizer (United States) (US), Pfizer (United Kingdom) (GB), Pfizer (Canada) (CA)
Pfizer
Openalex Percentile: Top 69%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.